Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tejnaksh HealthcareBOM:539428 +1.23%67 Return-on-Tangible-Equity is 6.08% as of Mar. 2026, which is 67% below its 10-year median of 18.34. GuruFocus rates BOM:539428 with a GF Score™ of 67/100 and a GF Value™ of ₹20.94 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 575 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks worse than 63.3% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Tejnaksh Healthcare's annualized net income for the quarter that ended in Mar. 2026 was ₹14.4 Mil. Tejnaksh Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹237.6 Mil. Therefore, Tejnaksh Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 6.08%.
The historical rank and industry rank for Tejnaksh Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
BOM:539428'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 5.31 Med: 18.34 Max: 56.15
Current: 5.32
During the past 12 years, Tejnaksh Healthcare's highest Return-on-Tangible-Equity was 56.15%. The lowest was 5.31%. And the median was 18.34%.
BOM:539428's Return-on-Tangible-Equity is ranked worse than 63.3% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 10.45
vs BOM:539428: 5.32
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Tejnaksh Healthcare Return-on-Tangible-Equity Related Terms
Tejnaksh Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Tejnaksh Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539428 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Tejnaksh Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tejnaksh Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Tejnaksh Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 6.08% mean?
Tejnaksh Healthcare (BOM:539428) has a Return-on-Tangible-Equity of 6.08% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Tejnaksh Healthcare and its competitors. This is 67% below median its historical median of 18.34. Over the past decade, Tejnaksh Healthcare's Return-on-Tangible-Equity has ranged from 5.31 to 56.15. According to the industry distribution chart, Tejnaksh Healthcare ranks #364 out of 575 companies in the Healthcare Providers & Services industry, placing it in the top 63.3%.
Is Tejnaksh Healthcare's Return-on-Tangible-Equity too high?
Tejnaksh Healthcare's current Return-on-Tangible-Equity of 6.08% is 67% below median its 10-year median of 18.34. Over the past 10 years, this metric has ranged from a low of 5.31 to a high of 56.15. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.45. Tejnaksh Healthcare's value of 6.08% is 41.8% below this industry median. Based on the distribution chart, Tejnaksh Healthcare ranks #364 out of 575 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tejnaksh Healthcare has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #364 out of 575 companies for Return-on-Tangible-Equity. This places Tejnaksh Healthcare in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.45. Tejnaksh Healthcare's value of 6.08% is 41.8% below this benchmark. Historically, Tejnaksh Healthcare's own Return-on-Tangible-Equity has ranged from 5.31 to 56.15 over the past decade. While the company's 10-year median is 18.34 vs. the industry median of 10.45, Tejnaksh Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.45, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tejnaksh Healthcare's current Return-on-Tangible-Equity of 6.08% is 41.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current Return-on-Tangible-Equity is 6.08%, which is 67% below median its own 10-year median of 18.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.94, compared to a current price of ₹14.00 — trading 33.1% below its estimated fair value. The current Return-on-Tangible-Equity is 6.08%, which is 67% below median its 10-year median of 18.34 and 41.8% below the Healthcare Providers & Services industry median of 10.45. Tejnaksh Healthcare's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current Return-on-Tangible-Equity is 6.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?
Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued.
The current stock price of ₹14.00 is trading 33.1% below its estimated GF Value™ of ₹20.94.
GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.
Key valuation signals for BOM:539428:
Return-on-Tangible-Equity: 6.08% (67% below median its 10-year median of 18.34)
GF Value™: ₹20.94 vs. price of ₹14.00 (33.1% below fair value)
Industry Position: 41.8% below the Healthcare Providers & Services median (#364 of 575)
No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
67GF Score
Get the complete analysis for BOM:539428
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539428 has been successfully added to your 
